Open Access

Erratum: Magnesium treatment in alcoholics: a randomized clinical trial

Substance Abuse Treatment, Prevention, and Policy20083:5

DOI: 10.1186/1747-597X-3-5

Received: 27 February 2008

Accepted: 27 February 2008

Published: 27 February 2008

The original article was published in Substance Abuse Treatment, Prevention, and Policy 2008 3:5

Correction

After publication of our work [1], we noticed that the magnesium (Mg) content of the trial tablets was inadvertently given as 250 mg. The correct content was 200 mg. Thus the first sentence under the subtitle "Intervention" should read: The patients received orally for 8 weeks either a daily dose of 400 mg of Mg tablets divided in two tablets (200 mg each) or matching placebo tablets.

Declarations

Acknowledgements

We thank Sirpa Päivinen, R.N. for patient data collection, the Töölö A-Clinic and Detoxification Unit (Finland) for recruiting the patients and providing facitilites, Pharma Nord (Denmark) for providing the trial drugs and corresponding placebos, and the Finnish Foundation for Alcohol Studies for financial support.

Authors’ Affiliations

(1)
Finnish Foundation for Alcohol Studies
(2)
National Public Health Institute (KTL), Department of Mental Health and Alcohol Research
(3)
Research Unit of Substance Abuse Medicine, University of Helsinki

References

  1. Poikolainen K, Alho H: Magnesium treatment in alcoholics: a randomized clinical trial. Substance Abuse Treatment, Prevention, and Policy. 2008, 3: 1-10.1186/1747-597X-3-1. (25 January 2008)PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Poikolainen and Alho; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement